Sale of Securities

Immunovant, Inc. Filed 2026-06-26 Acc 0001950047-26-006532

Documents 1

2026-06-26 144 Sale of Securities
2026-06-26 144 Sale of Securities
2026-06-26 144 Sale of Securities
2026-06-26 4 Chief Operating Officer sold 17,714 shares at an average $38.31 ($678,604)
2026-06-26 4 Chief Technology Officer sold 40,000 shares at an average $38.31 ($1,532,309)
2026-06-26 4 Chief Legal Officer sold 17,824 shares at an average $38.31 ($682,887)
2026-06-26 4 Chief Financial Officer sold 10,000 shares at $38.46 ($384,600)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…